Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: Benchmark for minimally invasive direct coronary artery bypass

Circulation

Volumn 100, Issue 23, 1999, Pages 2353-2358

  Berger, Peter B ^a   Alderman, Edwin L ^b   Nadel, Andrea ^c   Schaff, Hartzell V ^d  

^a MAYO CLINIC   (United States)

^b STANFORD UNIVERSITY   (United States)

^c BAYER CORPORATION   (United States)

^d Mayo Clinic ^*

Author keywords

Angiography; Cardiopulmonary bypass; Coronary disease; Revascularization; Trials

Indexed keywords

APROTININ; HEPARIN; PROTAMINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SURGERY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERNAL MAMMARY ARTERY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS;

EID: 0033534083     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.23.2353     Document Type: Article

References (33)

1. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S. Starting aspirin therapy after operation: effects on early graft patency: Department of Veterans Affairs Cooperative Study Group. Circulation. 1991;84:520-526.
2. Sethi GK, Copeland JG, Moritz T, Henderson W, Zadina K, Goldman S. Comparison of postoperative complications between saphenous vein and IMA grafts to left anterior descending coronary artery. Ann Thorac Surg. 1991;51:733-738.
3. Van de Meer J, de la Riviere AB, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PHJM, Mulder BJM, Lie KI, for the CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. J Am Coll Cardiol. 1994;24:1181-1188.
4. Benetti FJ, Ballester C, Sani G, Doonstra P, Grandjean J. Video-assisted mini-invasive coronary surgery without cardiopulmonary bypass: a multicenter study. J Thorac Surg. 1995;10:620-625.
5. Boonstra PW, Grandjean JG, Mariana MA. Improved method for direct coronary grafting without CPB via anterolateral small thoracotomy. Ann Thorac Surg. 1997;3:567-569.
6. Holubkov R, Zenati M, Akin JJ, Erb L, Courcoulas A. MIDCAB characteristics and results: the CardioThoracic Systems (CTS) registry. Eur J Cardiothorac Surg. 1998;14(Suppl 1):S25-S30.
7. Mariani MA, Boonstra PW, Grandjean JG, Peels JOJ, Monnink SHJ, Heijer PD, Crijns JJGM. Minimally invasive coronary artery bypass grafting versus coronary angioplasty for isolated type C stenosis of the left anterior descending artery. J Thorac Cardiovasc Surg. 1997;114: 434-439.
8. Alderman EL, Levy JH, Rich J, Nili M, Vidne B, Schaff H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A, on behalf of the IMAGE Investigators. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg. 1998;116: 716-730.
9. Laskowski M Jr, Kato I. Protein inhibitors of proteinases. Annu Rev Biochem. 1980:49:593-626.
10. Havel M. Grabenwoger F, Schneider J, Laufer G, Wollenek G, Owen A, Simon P, Teufelsbauer H, Wolner E. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing post-operative bleeding and use of donated blood. J Thorac Cardiovasc Surg. 1994;107:807-810.
11. Verstraete M. Clinical applications of inhibitors of fibrinolysis. Drugs. 1985;29:236-242.
12. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987; 2:1289-1291.
13. Van Oeveren W, Jansen NJ, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CRH. Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg. 1987;44:640-645.
14. Bidstrup BP, Royston D, Taylor KM, Sapsford RN. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989;97:364-372.
15. Cosgrove DM, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LA, Stewart RW, McCarthy PM, Loop FD. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg. 1992;6:1031-1036.
16. Lemmer J, Stanford W, Bonney S, Breen J, Chomka E, Eldredge WJ, Holt WW, Karp RB, Laub GW, Lipton MJ, Schaff HV, Tatooles CJ, Rumberger JA. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg. 1994;107:543-553.
17. Lemmer JH Jr, Dilling EW, Morton JR, Rich JR, Robicsek F, Bricker DL, Hantler CB, Copeland JG III, Ochsner JL, Daily PO, Whitten CW, Noon GP, Maddi R. Aprotinin for primary coronary artery bypass grafting: a multicenter trial of 3 dose regimens. Ann Thorac Surg. 1996;62: 1659-1668.
18. Levy JH, Pifarre R, Schaff HV, Horrow JC, Albus R, Spiess B, Rosengart TK, Murray J, Clark RE, Smith P, Nadel A, Bonney SL, Kleinfield R. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation. 1995;92:2236-2244.
19. Prinieas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiograph Findings: Standards and Procedures for Measurement and Classification. Boston, Mass: Wright-PSG; 1982:1-229.
20. Rautaharju PM, Calhoun HP, Chaitman BR. Novacode serial ECG classification system for clinical trials in epidemiological studies. J Electrocardiol. 1992;24:179-187.
21. Chaitman BR, Alderman EL, Sheffield LT, Tong T, Fisher L, Mock MB, Wiens RD, Kaiser GC, Roitman D, Berger R, Gersh B, Schaff H, Bourassa MG, Killip T, and participating CASS medical centers. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation. 1983;67:302-309.
22. Chaitman BR, Zhaou SH, Tamesis B, Rosen A, Terry AB, Zumbehl KM, Stocke K, Takase EB, Gussak I, Rautaharju PM. Methodology of serial ECG classification using an adaptation of the Novacode for Q wave myocardial infarction in the bypass angioplasty revascularization investigation (BARI). J Electrocardiol. 1996;29:265-277.
23. Cameron AAC, Green GE, Brogno DA, Thornton J. Internal thoracic artery grafts: 20-year clinical follow-up. J Am Coll Cordiol. 1995;25: 188-192.
24. Boylan MJ, Lytle BW, Loop FD, Taylor PC, Borsh JA, Goormastic M, Cosgrove DM. Surgical treatment of isolated left anterior descending coronary artery stenosis: comparison of left internal mammary artery and venous autograft at 18 to 20 years follow-up. J Thorac Cardiovasc Surg. 1994;107:657-662.
25. Okies JE, Page US, Bigelow JC, Krause AH, Salomon NW. The left internal mammary artery: the graft of choice. Circulation. 1986;74(suppl I):I-213-I-221.
26. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts: effects of survival over a 15-year period. N Engl J Med. 1996;334:216-219.
27. Barner HB, Standeven JW, Reese J. Twelve-year experience with internal mammary artery for coronary artery bypass. J Thorac Cardiovasc Surg. 1985;90:668-675.
28. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LAR, Gill CC, Taylor PC, Sheldon WC, Prouditt WL. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
29. Bjork VO, Ivert T, Landou C. Angiographic changes in internal mammary artery and saphenous vein grafts, 2 weeks, 1 year, and 5 years after coronary bypass surgery. Scand J Thorac Cardiovasc Surg. 1981;15:23-30.
30. Grondin CM, Campeau L, Lesperance J, Enjalbert M, Bourassa MG. Comparison of late changes in internal mammary artery and saphenous vein grafts in 2 consecutive series of patients 10 years after operation. Circulation. 1984;70(suppl I):I-208-I-212.
31. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Kern KB, Sethi G, Sharma GV, Khuri S, Richards K, Grover F, Morrison D, Johnston M, Chesler E, Sako Y, Pacold I, Montoya A, DeMots H, Floten S, Doherty J, Read R, Scott S, Spooner T, Masud Z, Haakenson C, Harker LA. Internal mammary artery and saphenous vein graft patency: effects of aspirin. Circulation. 1990;82(suppl IV): IV-237-IV-242.
32. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
33. Fleming RM, Kirkeeide RL, Smalling RW, Gould KL. Patterns in visual interpretation of coronary angiograms as detected by quantitative coronary angiography. J Am Coll Cardiol. 1991;18:945-951.